Interdisciplinary gene manipulation, molecular cloning, and recombinant expression of modified human growth hormone isoform-1 in E. coli system

Copyright © 2023 Elsevier B.V. All rights reserved..

BACKGROUND: Growth hormone (GH) is a hormone that promotes growth, cell reproduction, and cell restoration in humans and animals.

OBJECTIVES: Production of recombinant human growth hormone (rhGH) in Escherichia coli (E. coli) and assessment of its characteristics and proliferation stimulatory activity.

METHODS: The hGH gene was cloned into a pET 3a expression vector and transformed into a competent E. coli cell. The refolded hGH was purified, Western blot and batch fermentation were performed. Cell cytotoxicity was tested on Vero cells, and MALDI-TOF and Nano-LC-ESI MS/MS were used for protein and target peptide analysis.

RESULTS: Induced rhGH was purified with a concentration of 511.9 mg/ml. Western blot confirmed the molecular identity of rhGH, showing a single 22 kDa band. The bacterial growth at OD600 after 24 h in batch fermentation was 9.78 ± 0.26, and wet cell weight (WCWg/L) was 15.2 ± 0.32. Purified rhGH activity on Vero cells was 0.535 IU/mg. LC-MS/MS analysis revealed a score of 70.51 % and coverage of 60.37 %.

CONCLUSION: Biologically active native rhGH protein was successfully expressed in the Prokaryotic system. Our goal is to increase its production on a pilot level in the native form at a high activity effect identical to isoform 1.

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - volume:257

Enthalten in:

International journal of biological macromolecules - 257(2024), Pt 1 vom: 01. Jan., Seite 128637

Sprache:

Englisch

Beteiligte Personen:

Nasr, Sami Mohamed [VerfasserIn]
Samir, Safia [VerfasserIn]
Okasha, Hend [VerfasserIn]

Links:

Volltext

Themen:

12629-01-5
9002-72-6
Batch fermentation
Escherichia coli
Growth Hormone
Growth hormone
Human Growth Hormone
Immunodetection
Journal Article
MALDI-TOF
Nano-LC-ESI MS/MS
Proliferation activity
Protein Isoforms
Recombinant Proteins
Recombinant drug
Vero cells

Anmerkungen:

Date Completed 26.01.2024

Date Revised 26.01.2024

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1016/j.ijbiomac.2023.128637

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM365524034